Patent details

Basic Information

Publication number:

EP2395984

PCT Application Number:

PCT/EP/2010/051735

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP107034746

PCT Publication Number:

WO/2010/092124

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PHARMACEUTICAL COMPOSITION COMPRISING LINAGLIPTIN AND A SGLT2 INHIBITOR,AND USES THEREOF

French Title of Invention:

COMPOSITION PHARMACEUTIQUE CONTENANT LINAGLIPTIN ET UN INHIBITEUR SGLT2

German Title of Invention:

PHARMAZEUTISCHE ZUSAMMENSETZUNG MIT LINAGLIPTIN UND EINEM SGLT2-INHIBITOR UND IHRE VERWENDUNG

SPC Number:

Dates

Filing date:

11/02/2010

Grant date:

19/10/2016

EP Publication Date:

19/10/2016

PCT Publication Date:

19/08/2010

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

21/12/2011

EP B1 Publication Date:

19/10/2016

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

11/02/2017

Expiration date:

11/02/2030

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

11/02/2010

 

 

Name:

Boehringer Ingelheim International GmbH

Address:

Binger Strasse 173, 55216 Ingelheim, Germany (DE)

Inventor

Name:

EISENREICH Wolfram

Address:

Germany (DE)

Priority

Priority Number:

152306 P

Priority Date:

13/02/2009

Priority Country:

United States (US)

Classification

Main IPC Class:

A61P 3/06;

Publication

European Patent Bulletin

Issue number:

201734

Publication date:

23/08/2017

Description:

Opposition procedure started

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages